Monday, July 13, 2026 Home
Startup Atlas · Diagnostics

PharmEasy Unicorn

API Holdings Limited Mumbai, Maharashtra Founded 2015 pharmeasy.in ↗
Dharmil Sheth · Co-founder (PharmEasy); stepped down from executive role in 2025 Dhaval Shah · Co-founder (PharmEasy); stepped down from executive role in 2025 Mikhil Innani · Co-founder (PharmEasy) Siddharth Shah · Co-founder (Ascent Health & Wellness, merged into API Holdings); former MD & CEO of API Holdings, now Vice Chairman Hardik Dedhia · Co-founder (Ascent Health & Wellness); stepped down from executive role in 2025 Harsh Parekh · Co-founder (Ascent Health & Wellness)
$1.35 BnTotal funding (tracked)
9Funding rounds
16 Sep 2025Last round
4,700Team size (sourced)

PharmEasy: Funding Rounds

Debt Financing: $5.5MSep '18Series C: $50MSep '18Series D: $220MNov '19Series E: $350MApr '21Secondary: $20MJun '21Series F: $300MJun '21Down round (rights issue): $216MApr '24Debt (NCDs): $193MSep '25

Disclosed round amounts over time, USD millions.

Date Round Amount Investors Source
16 Sep 2025 Debt (NCDs) ₹1,700 Cr (~$193 Mn) 360 One Alkram Ventures Bennett Coleman Micro Labs Limited MVS Ventures source
30 Apr 2024 Down round (rights issue) $216 Mn (~₹1,804 Cr) Manipal Education and Medical Group (MEMG) / Ranjan Pai 360 One Portfolios CDPQ Private Equity Evolution Debt Capital Goldman Sachs Prosus Temasek WSSS Investments source
7 Nov 2022 Debt Financing Undisclosed EvolutionX Debt Capital source
28 Jun 2021 Series F $300 Mn Kotak Investment Advisors B Capital Prosus Temasek Think Investments TPG source
17 Jun 2021 Secondary $20 Mn B Capital source
7 Apr 2021 Series E $350 Mn ($323 Mn closed as primary/secondary) TPG Growth CDPQ Eight Roads LGT Lightrock Prosus Ventures Temasek Think Investments source
28 Nov 2019 Series D $220 Mn Temasek source
26 Sep 2018 Series C $50 Mn Eight Roads Ventures India Bessemer Venture Partners F-Prime Capital Fundamentum Advisors Think Investments source
10 Sep 2018 Debt Financing $5.5 Mn InnoVen Capital source

PharmEasy: Investors

360 One Alkram Ventures Bennett Coleman Micro Labs Limited MVS Ventures Manipal Education and Medical Group (MEMG) / Ranjan Pai 360 One Portfolios CDPQ Private Equity Evolution Debt Capital Goldman Sachs Prosus Temasek WSSS Investments EvolutionX Debt Capital Kotak Investment Advisors B Capital Think Investments TPG TPG Growth CDPQ Eight Roads LGT Lightrock Prosus Ventures Eight Roads Ventures India Bessemer Venture Partners F-Prime Capital Fundamentum Advisors InnoVen Capital

Acquisitions

DateAcquirerAcquiredAmountSource
14 Sep 2021 PharmEasy aknamed $144 Mn enterprise valuation (₹1,060 Cr) for a 67.3% controlling stake source
25 Jun 2021 PharmEasy thyrocare-technologies ₹4,546 Cr (~$613.5 Mn) for a 66.1% stake source
25 May 2021 PharmEasy medlife $250 Mn (reported, all-stock deal) source

FAQs on PharmEasy

How much funding has PharmEasy raised?

PharmEasy has raised $1.35 Bn across 9 tracked funding round(s), most recently on 2025-09-16. Figures are compiled from cited public sources.

Who are the investors in PharmEasy?

Investors in PharmEasy include 360 One, Alkram Ventures, Bennett Coleman, Micro Labs Limited, MVS Ventures, Manipal Education and Medical Group (MEMG) / Ranjan Pai, 360 One Portfolios, CDPQ Private Equity.

Sources & corrections. Every fact on this page is compiled from cited public sources — follow the “source” links beside each entry. Profile sources: inc42.com · Last verified 13 Jul 2026. · Report a correction